LS Securities maintained its target stock price at 2.4 million won on the 16th, saying that SK

LS Securities maintained its 2.4 million won target price for SK Hynix, citing strong AI semiconductor demand and shareholder return policies. The firm expects Q4 sales to rise 19.6% to 125.1 trillion won and operating profit to increase 22.4% to 102 trillion won. HBM4 supply expansion and high-value product sales are key growth drivers. Long-term contracts and high customer demand support profitability. Shareholder returns, including dividends and stock buybacks, are also highlighted.

Original reporting
Published Nov 15, 2026, 11:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 15, 2026, 11:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
LS Securities maintained its target stock price at 2.4 million won on the 16th, saying that SK — source image
Decision brief

The 30-second read

$000660.KSBullishMed
01

Why it matters

The guidance suggests a significant earnings upside, which could attract new buying interest and lift the stock.

02

Market read

Fresh earnings guidance for a major AI‑chip supplier can move the stock and influence the broader semiconductor sector.

03

What to watch

Potential oversupply risk if competitors accelerate HBM4 production faster than forecasted.

Relevance 7/10Novelty 7/10Timing: immediate

Background

The article is an analyst note from LS Securities maintaining a buy rating on SK Hynix and presenting new multi‑year profit and dividend forecasts.

Company-level read

Ticker impact

$000660.KSBullishHigh confidence
Context

LS Securities issued a fresh buy rating and detailed 2027-2028 profit forecasts for SK Hynix, including projected operating profit of 528.1 trillion won in 2027 and a 100‑trillion‑won shareholder return plan.

Expected impact

likely upward pressure as investors price in higher profit guidance and dividend yield.

Evidence & confidence

The report provides new quantitative guidance and a buy recommendation, which can prompt buying activity.

Market effects

Positive outlook for the AI‑semiconductor sector as demand for HBM4 is expected to rise.

May boost South Korean semiconductor stocks and related supply‑chain equities.

Supports broader AI‑chip rally, potentially influencing global tech indices.

Counterpoint

If global AI capex peaks earlier than expected, demand could soften, limiting upside.

Key entities

  • SK Hynix

    South Korean memory‑chip maker targeted by LS Securities.

  • LS Securities

    Research house issuing the buy rating and forecasts.

Related articles

$MUMed

Samsung, SK hynix and Micron fail to dismiss DRAM supply lawsuit

A US judge allowed a lawsuit against Samsung, SK hynix, and Micron over alleged DRAM supply restrictions to proceed, rejecting their dismissal attempt. The case, brought by 17 consumers and small businesses, alleges the manufacturers restricted conventional DRAM supply while shifting to high-bandwidth memory for AI hardware. The judge found sufficient detail in the allegations for the case to continue, with the companies required to respond by 7 December.

$MUMed

Federal Judge Lets DRAM Price-Fixing Suit Against Micron, Samsung and SK hynix Proceed

A federal judge in California allowed a class-action lawsuit against Micron, Samsung, and SK hynix to proceed, alleging DRAM price-fixing. The plaintiffs claim the companies restricted supply and raised prices. The court found the complaint plausible, citing coordinated actions. The case may impact the companies' earnings and market dynamics, with a legal overhang despite denied wrongdoing.

$MUMed

Judge denies motion to dismiss DRAM price-fixing lawsuit against Micron, Samsung, and SK hynix, finds evidence of DRAM collusion plausible after 500% price surge — says chipmakers acted like ‘hawks flying in formation'

A judge denied Micron, Samsung, and SK hynix's motion to dismiss a DRAM price-fixing lawsuit, finding evidence of collusion plausible. The plaintiffs allege coordinated actions led to a 500% price surge. The companies argue their actions were independent responses to market conditions. The case will proceed, with the next hearing set for 2027.